Synthesis and biological evaluation of some novel benzoxazin-4-one and quinazolin-4-one derivatives based on anti-inflammatory commercial drugs

Authors

DOI:

https://doi.org/10.5564/mjc.v25i51.3121

Keywords:

anti-inflammatory, analgesic, Benzoxazinone, Heterocyclic, Quinazolinone

Abstract

Benzoxazine and quinazoline are nitrogen-containing heterocyclic scaffolds found in various biologically active compounds. Due to their diverse biological actions, these heterocyclic rings serve as crucial frameworks for designing medicinal compounds. This study aimed to synthesize and assess in vivo anti-inflammatory, analgesic, and low ulcerogenic potential of a few novel benz[d][1,3]-oxazin-4-one and quinazolinone derivatives. Benzoxazinones (3a-e) were synthesized by cyclizing the carboxylic group (-COOH) of five nonsteroidal anti-inflammatory drugs viz., aceclofenac, ibuprofen, diclofenac, mefenamic acid and ketoprofen (2a-e) with anthranilic acid (1) using dry phosphorus oxychloride (POCl3) in pyridine. The corresponding quinazolinone derivatives (5a-e) were obtained by reacting 3a-e with isonicotinic acid hydrazide (4). Both sets of compounds were evaluated for their anti-inflammatory, analgesic effects, and ulcerogenicity in animal models. Structural characterization was performed using spectral analysis. Among the benzoxazinone derivatives, compound 2-(2-((2,6-dichlorophenyl) amino) benzyl)-4H-benzo[d][1,3]oxazin-4-one (3d) exhibited significant anti-inflammatory activity (62.61% inhibition of rat paw edema) and analgesic activity (62.36% protection in acetic acid-induced writhings) with tolerable gastrointestinal toxicity (2.67 ulcerogenicity index) compared to quinazolinone derivatives. The results of anti-inflammatory and analgesic activities of both the series are comparable with the respective, positive control. Compound 3d, a benzoxazinone-diclofenac hybrid, emerged as a lead molecule with potent anti-inflammatory, analgesic activities and moderate gastric toxicity showcasing the promising potential for further development.

Downloads

Download data is not yet available.
Abstract
99
PDF
132

References

Bindu S., Mazumder S., Bandyopadhyay U. (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem. Pharmacol., 180, 114147. https://doi.org/10.1016/j.bcp.2020.114147

Knights K.M., Mangoni A.A., Miners J.O. (2010) Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity. Expert Rev. Clin. Pharmacol., 3, 769-776. https://doi.org/10.1586/ecp.10.120

Brzozowski T., Konturek P.C.,Konturek S.J., Sliwowski Z., Pajdo R., et al. (2001) Classic NSAID and selective cyclooxygenase (COX)‐1 and COX‐2 inhibitors in healing of chronic gastric ulcers. Microsc. Res. Tech., 53, 343-353. https://doi.org/10.1002/jemt.1102

Davies N.M., Jamali F. (2004) COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter. J. Pharm. Pharm. Sci., 7, 332-336.

Sun S.X., Lee K.Y., Bertram C.T., Goldstein J.L. (2007) Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization. Curr. Med. Res. Opin., 23, 1859-1866. https://doi.org/10.1185/030079907X210561

Gatti D., Adami S. (2010) Coxibs: a significant therapeutic opportunity. Acta Biomed., 81, 217-224.

Kaur A., Pathak D.P., Sharma V., Wakode S. (2018) Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Bioorg. Med. Chem., 26, 891-902. https://doi.org/10.1016/j.bmc.2018.01.007

Khan S.A., Imam S.M., Ahmad A., Basha S.H. (2018) Synthesis, molecular docking with COX 1& II enzyme, ADMET screening and in vivo anti-inflammatory activity of oxadiazole, thiadiazole and triazole analogs of felbinac. J. Saudi Chem. Soc., 22, 469-484. https://doi.org/10.1016/j.jscs.2017.05.006

Amir M., Oberoi A., Alam S. (1999) Synthesis and antiinflammatory activity of some new 6‐methoxy‐α‐methyl‐2‐naphthalene acetic acid derivatives. Ind. J. Chem., 38, 237-239. https://doi.org/10.1002/chin.199931054

Sharma S., Kumar D., Singh G., Monga V., Kumar B. (2020) Recent advancements in the development of heterocyclic anti-inflammatory agents. Euro. J. Med. Chem., 200, 112438. https://doi.org/10.1016/j.ejmech.2020.112438

Hekal M.H., Abu El-Azm F.S. (2018) New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: synthesis and cytotoxic evaluation. Synth. Commun., 48, 2391-2402. https://doi.org/10.1080/00397911.2018.1490433

Bollu R., Banu S., Kasaboina S., Bantu R., Nagarapu L., et al. (2017) Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates. Bioorg. Med. Chem. Lett., 27, 5481-5484. https://doi.org/10.1016/j.bmcl.2017.10.044

Sakr A., Kothayer H., Ibrahim S.M., Baraka M.M., Rezq S. (2019) 1,4-dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study. Bioorg. Chem., 84, 76-86. https://doi.org/10.1016/j.bioorg.2018.11.030

Laddha S.S., Wadodkar S.G., Meghal S.K. (2006) Studies on some biologically active substituted 4(3H)-quinazolinones. Part 1. Synthesis, characterization and anti-inflammatory-antimicrobial activity of 6,8-disubstituted 2-phenyl-3-[substituted-benzothiazol-2-yl]-4(3H)-quinazolinones. Arkivoc., 11, 1-20. https://doi.org/10.3998/ark.5550190.0007.b01

Bollu R., Palem J.D., Bantu R., Guguloth V., Nagarapu L., et al. (2015) Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids. Eur. J. Med. Chem., 89, 138-146. https://doi.org/10.1016/j.ejmech.2014.10.051

Zahoor A.F., Yousaf M., Siddique R., Ahmad S., Naqvi S.A.R., et al. (2017) Synthetic strategies toward the synthesis of enoxacin-, levofloxacin-, and gatifloxacin-based compounds: A review. Synth. Commun., 47, 1021-1039. https://doi.org/10.1080/00397911.2017.1300921

Giubellina N., Stabile P., Laval G., Perboni A.D., Cimarosti Z., et al. (2010) Development of an efficient large-scale synthesis for a 4h-imidazo [5,1-c][1,4] benzoxazine-3-carboxamide derivative for depression and anxiety. Org. Process Res. Dev., 14, 859-867. https://doi.org/10.1021/op100103v

Foroumadi A., Emami S., Mansouri S., Javidnia A., Saeid-Adeli N., et al. (2007) Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring. Euro. J. Med. Chem., 42, 985-992. https://doi.org/10.1016/j.ejmech.2006.12.034

Khalaj A., Abdollahi M., Kebriaeezadeh A., Adibpour N., Pandi Z., et al. (2002) The antinociceptive and antiinflammatory activities and lack of ulcerogenicity of a benzodioxin-4-one and its analog benzoxazine as cyclic acetal-like derivatives of salicylic acid and salicylamide in mice and rats. Indian J. Pharmacol., 34, 184-188.

Mhaske S.B., Argade N.P. (2006) The chemistry of recently isolated naturally occurring quinazolinone alkaloids. Tetrahedron, 62, 9787-9826. https://doi.org/10.1016/j.tet.2006.07.098

Sharma P.C., Kaur G., Pahwa R., Sharma A., Rajak H. (2011) Quinazolinone analogs as potential therapeutic agents. Curr. Med. Chem., 18, 4786-4812. https://doi.org/10.2174/092986711797535326

He D., Wang M., Zhao S., Shu Y., Zeng H., et al. (2017) Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives. Fitoterapia, 119, 136-149. https://doi.org/10.1016/j.fitote.2017.05.001

Auti P.S., George G., Paul A.T. (2020) Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids. RSC Adv., 10, 41353-41392. https://doi.org/10.1039/D0RA06642G

Alsibaee A.M., Al-Yousef H.M., Al-Salem H.S. (2023) Quinazolinones, the winning horse in drug discovery. Molecules, 28(3), 978 https://doi.org/10.3390/molecules28030978

Al-Deeb A.O., Alafeefy A.M. (2008) Synthesis of some new 3H-quinazolin-4-one derivatives as potential antitubercular agents. World Appl. Sci. J., 5, 94-99.

Alagarsamy V., Muthukumar V., Pavalarani N., Vasanthanathan P., Revathi R. (2003) Synthesis, analgesic and anti-inflammatory activities of some novel 2,3-disubstituted quinazolin-4(3H)-ones. Biol. Pharm. Bull., 26, 557-559. https://doi.org/10.1248/bpb.26.557

El-Hashash M.A.E.A., Azab M.E., Faty R.A.E.A., Amr A.E.G.E. (2016) Synthesis, antimicrobial and anti-inflammatory activity of some new benzoxazinone and quinazolinone candidates. Chem. Pharm. Bull., 64, 263-271. https://doi.org/10.1248/cpb.c15-00904

Tomić M., Micov A., Pecikoza U., Stepanović-Petrović R. (2017) Clinical uses of nonsteroidal anti-inflammatory drugs (NSAIDs) and potential benefits of NSAIDs modified-release preparations. In Microsized and nanosized carriers for nonsteroidal anti-inflammatory drugs; Elsevier, 1-29. https://doi.org/10.1016/B978-0-12-804017-1.00001-7

Husain A., AlAsmari A.F., Azmi S.N.H., Ali N., Sarker M.M.R. et al. (2022) Rational drug design, synthesis, and in vivo biological activity of new indolyl-imidazolone hybrids as potential and safer non-steroidal anti-inflammatory agents. J. King Saud Univ.Sci., 34, 102023. https://doi.org/10.1016/j.jksus.2022.102023

Husain A., Ahuja P., Ahmad A., Khan S.A. (2016) Synthesis, biological evaluation and pharmacokinetic studies of mefenamic acid-N-hydroxymethylsuccinimide ester prodrug as safer NSAID. Med. Chem., 12, 585-591. https://doi.org/10.2174/1573406412666160107113548

Husain A., Ahmad A., Khan S.A., Asif M., Bhutani R., et al. (2016) Synthesis, molecular properties, toxicity and biological evaluation of some new substituted imidazolidine derivatives in search of potent anti-inflammatory agents. Saudi Pharm. J., 24, 104-114. https://doi.org/10.1016/j.jsps.2015.02.008

Akhter M., Husain A., Akhter N., Khan M.S.Y. (2011) Synthesis, anti-inflammatory and antimicrobial activity of some new 1-(3-Phenyl-3,4-Dihydro-2H-1,3-Benzoxazin-6-yl)-ethanone derivatives. Indian J. Pharm. Sci., 73, 101. https://doi.org/10.4103/0250-474X.89767

Zayed M.F., Hassan M.H. (2014) Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm. J., 22, 157-162. https://doi.org/10.1016/j.jsps.2013.03.004

Downloads

Published

2024-04-22

How to Cite

Khan, S. A., Ahuja, P. ., & Husain, A. (2024). Synthesis and biological evaluation of some novel benzoxazin-4-one and quinazolin-4-one derivatives based on anti-inflammatory commercial drugs. Mongolian Journal of Chemistry, 25(51), 35–44. https://doi.org/10.5564/mjc.v25i51.3121

Issue

Section

Articles